SCHEMBL1992879

SCHEMBL1992879

CCOC(=O)C(=O)c1cn(C(=O)OC(C)(C)C)c2sccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
BCHE P06276 2/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
HTR6 P50406 1/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
ALDH1A1 P00352 3/20 0.32
PKM P14618 1/20 0.32
HTR1A P08908 1/20 0.32
GAA P10253 3/20 0.32
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994321 0.87 BCHE (0.35) L3MBTL1KMT2AMEN1BCHEHTR6
SCHEMBL12631144 0.84 BCHE (0.36) L3MBTL1BCHEHTR6
SCHEMBL1995769 0.84 KMT2A (0.36) L3MBTL1KMT2AMEN1HTTATM
SCHEMBL1988689 0.82 L3MBTL1 (0.46) L3MBTL1KMT2AMEN1BCHECRHBP
SCHEMBL1998282 0.79 L3MBTL1 (0.65) L3MBTL1KMT2AMEN1BCHEHTR6
SCHEMBL2011042 0.75 L3MBTL1 (0.48) L3MBTL1KMT2AMEN1HTR6ALDH1A1
SCHEMBL2012738 0.75 L3MBTL1 (0.48) L3MBTL1KMT2AMEN1HTR6ALDH1A1
SCHEMBL12631148 0.73 PTGDR2 (0.48) L3MBTL1BCHEHTR6
SCHEMBL28935680 0.73 L3MBTL1 (0.46) L3MBTL1BCHEHTR6
SCHEMBL28935728 0.73 L3MBTL1 (0.41) L3MBTL1BCHEHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO L3MBTL1 3898/4885KMT2A 3648/4885MEN1 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.